Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Launching PODRAS human trials should be significant simply because it then positions them favorably to potentially finally secure a MONSTA R&D partner for it which they're definitely gonna need.

Launching the long anticipated oral and nasal studies on their oxy candidate simply starts the 6 month speculation clock on when they'll be in a position to refile it with the FDA. So I agree that it won't be that significant...but it will at least start building in speculation again...something we've been severely lacking since last July's adcom outcome glty